The Christie NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: -

Website: http://www.christie.nhs.uk/

Clinical Trials

Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer

Early Phase 1

Completed

Conditions: Ovarian Cancer

Interventions: Drug: Olaparib
Drug: Cediranib
Drug: Platinum-based Chemotherapy

First Posted Date: 2016-08-04

Last Posted Date: 2022-02-22

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 28

Registration Number: NCT02855697

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Counselling
Other: Patient diary PROMs

First Posted Date: 2015-07-24

Last Posted Date: 2023-02-22

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 64

Registration Number: NCT02507804

Locations: 🇬🇧
Christie NHS Foundation Trust, Manchester, United Kingdom

Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer

Completed

Conditions: Metastatic Castration Resistant Prostate Cancer

Interventions: Procedure: Biopsies, blood and urine samples

First Posted Date: 2015-04-23

Last Posted Date: 2016-07-26

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 6

Registration Number: NCT02424448

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers

Phase 1

Completed

Conditions: Biliary Tract Cancer
Gallbladder Cancer
Cholangiocarcinoma
Ampullary Cancer

Interventions: Drug: Acelarin
Drug: Cisplatin

First Posted Date: 2015-01-30

Last Posted Date: 2023-05-17

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 21

Registration Number: NCT02351765

Locations: 🇬🇧
Beatson Oncology Centre, Glasgow, United Kingdom
🇬🇧
Clatterbridge Cancer Centre, Liverpool, United Kingdom
🇬🇧
Imperial College London, London, United Kingdom

and more 2 locations

Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma

Phase 2

Completed

Conditions: Breast Cancer
Multiple Myeloma
Gastrointestinal Cancer
Gynaecological Cancer

Interventions: Procedure: Acupuncture
Other: Medication taken to manage the symptom burden of CIPN

First Posted Date: 2014-10-27

Last Posted Date: 2019-01-31

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 120

Registration Number: NCT02275403

Locations: 🇬🇧
The Royal Oldham Hospital, Oldham, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer

Withdrawn

Conditions: Squamous Cell Carcinoma of the Anus

Interventions: Procedure: Sentinel lymph node biopsy

First Posted Date: 2014-06-13

Last Posted Date: 2015-06-03

Lead Sponsor: The Christie NHS Foundation Trust

Registration Number: NCT02162641

PLX3397 KIT in Acral aNd mucOsal Melanoma

Phase 2

Completed

Conditions: Malignant Melanoma

Interventions: Drug: PLX3397

First Posted Date: 2014-02-26

Last Posted Date: 2021-08-12

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 7

Registration Number: NCT02071940

Locations: 🇬🇧
The Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
🇬🇧
Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Swansea, Wales, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

and more 5 locations

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer

Phase 1

Terminated

Conditions: Neoplasms, Ovarian
Ovarian Neoplasms
Ovarian Cancer

Interventions: Drug: Pazopanib
Drug: Fosbretabulin

First Posted Date: 2014-02-05

Last Posted Date: 2021-05-17

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 21

Registration Number: NCT02055690

Locations: 🇬🇧
University Collage London Hospitals NHS Foundation Trust, London, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom
🇬🇧
Freeman Hospital (Newcastle-upon-Tyne Hospitals NHS Foundation Trust), Newcastle Upon Tyne, United Kingdom

and more 7 locations

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Phase 2

Terminated

Conditions: Metastatic Melanoma

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Genetic: Tumour Infiltrating Lymphocytes
Drug: Interleukin-2

First Posted Date: 2013-11-26

Last Posted Date: 2023-04-20

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 2

Registration Number: NCT01995344

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study

Not Applicable

Completed

Conditions: Sarcoma

Interventions: Device: MRI scanning

First Posted Date: 2013-10-08

Last Posted Date: 2017-04-26

Lead Sponsor: The Christie NHS Foundation Trust

Target Recruit Count: 15

Registration Number: NCT01956019

Locations: 🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy